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Clinical investigation, using cerebral metabolic assessment with positron emission 
tomography, magnetic resonance spectroscopy and regional cerebral microdialysis, 
has repeatedly disclosed major alterations of neuroenergetics in the aftermath of 
traumatic brain injury (TBI). Impairment of neuroenergetics is characterized by 
elevated cerebral glucose demand, increased glycolysis and diversion of the main 
substrate, glucose, to be used in injury-related reparative pathways, such as the 
pentose-phosphate pathway (PPP) 1. Ultimately, these secondary processes lead 
to cerebral metabolic glucose depression, decreased availability of cerebral 
extracellular glucose and energy dysfunction, which in turn exacerbates brain 
damage and may worsen neurological recovery 2. Use of alternative cerebral 
energy substrates – including lactate (LAC) and ketone bodies (KB, including β-
hydroxy-butyrate BHB and acetoacetate AcAc), to compensate for glucose 
shortage, may therefore be a key adaptive mechanism following TBI. Further, LAC 
and KB may provide improved substrate availability, as their transport to the brain via 
mono-carboxylate transporters (MCT) is up-regulated after TBI 3. 
Alternative energetic substrates to glucose for the brain: lactate and ketones 
Increased astrocyte glycolysis generates LAC, which trans-locates to the brain 
extracellular space.  This astrocytic glycolysis is not accompanied by oxidative 
metabolism of substrates, even in the presence of oxygen (hence termed aerobic 
glycolysis), which recapitulates obligate glycolytic metabolism in cancer cells 
(Warburg effect). LAC can be transferred to neurons (astrocyte-neuron lactate 
shuttle), and provide a substrate for neuronal energetic needs, while also acting as a 
modulator of various essential neuronal functions, including excitability, plasticity and 
memory consolidation 4. 
The main source of KB is from endogenous ketosis, through lipolysis and hepatic 
metabolism of free fatty acids. Astrocytes are also able to generate KB locally. 
Plasma and local brain derived KB bypass glycolysis to provide substrates that 
directly enter the tricarboxylic acid (TCA) cycle (a process known as anaplerosis) and 
can be metabolized to provide energy in mitochondria, where the TCA cycle is linked 
to the generation of adenosine triphosphate (ATP). Apart from their energetic 
function, KB have key neurotrophic and neuroprotective properties, including up-
regulated expression of brain-derived neurotrophic factor, reduction of oxidative 
stress, promotion of mitochondrial biogenesis, and enhancing synaptic plasticity and 


































































Therapeutic energy supplementation after TBI 
Lactate therapy 
Exogenous supplemental LAC can be administered in the form of hyperosmolar 
(hypertonic) sodium lactate (Na-LAC) solutions. Experimentally, Na-LAC (given 
intravenously or by direct intraventricular administration) attenuates lesion extent and 
cognitive dysfunction, and promotes synaptic plasticity and memory consolidation 
4. In patients with TBI, sodium 3-13C-labelled LAC – administered locally through a
cerebral microdialysis catheter 6, or intravenously 2, 7 – can be effectively utilized 
by the injured brain, with favorable effects on regional neuroenergetics 6. Systemic 
administration of intravenous Na-LAC (30 μmol/kg/min, to raise blood arterial lactate 
to 2-4 mmol/L) increases the availability of cerebral microdialysis glucose and has 
additional favorable effects on the cerebral circulation, by reducing intracranial 
pressure and improving cerebral blood flow 8. Na-LAC has other potentially 
advantageous systemic effects: contrary to chloride, contained in standard 
hypertonic saline solutions, LAC is an active metabolic substrate, therefore Na-LAC 
therapy may prevent hyperchloremic acidosis 9. Lactate may have additional 
benefits in terms of signaling, but these have not been explored in humans. 
Ketone therapy 
Exogenous ketone therapy can be delivered under the form of ketogenic diets (KD), 
using enteral formulas enriched with medium-chain triglycerides (MCT, comprising 
octanoic and decanoic acids). KD has been repeatedly tested in experimental and 
clinical studies as a non-pharmacological approach to the treatment of refractory 
epilepsy, diabetes, brain cancer and neurodegenerative disorders 10. Regarding 
acute phase treatment, continuous enteral feeding using KD takes ≈ 3-5 days to 
reach stable therapeutic blood KB levels (2-4 mmol/L; compared 0.1-0.2 mmol/L in 
untreated subjects) 11, while MCT enriched enteral KD boluses may only achieve ≈ 
0.5-0.6 mmol/L blood KB levels 12. Ketone supplementation also can be achieved 
exogenously in a more direct form, by way of enteral administration of ketone esters 
(KE) or ketone salts (KS) 13 that allow rapid increase (within 30 min) of blood KB to 
therapeutic levels comparable to those obtained by intravenous Na-BHB solutions 
14.
Ketone supplementation has various neuroprotective effects in experimental models 
of brain injury 15, in particular by attenuating seizures 16 and oxidative stress 


































































degradation of histone deacetylation is involved in memory and cognitive 
impairments seen in neurodegenerative diseases, therefore HDAC inhibition by KB 
therapy might translate into improved or restored cognitive recovery following TBI. A 
recent clinical investigation in subjects with TBI demonstrated that brain 
microdialysate KB levels were consistently increased during fasting (when compared 
to the fed state) and correlated well with systemic KB levels, implying effective KB 
transfer from the systemic circulation to the injured brain, and suggesting a potential 
therapeutic role for KB supplementation 18. Enteral KB supplementation improves 
cerebral oxidative metabolism (increased NAD+/NADH) in healthy volunteers 12 
and provides extra energy under the form of acetyl-CoA to the TCA cycle, thereby 
reducing the reliance on glycolysis, in athletes 19. Systemic Na-BHB administration 
has been recently shown to achieve effects comparable to Na-LAC on 
neuroenergetics, by reducing cerebral glucose consumption (glucose sparing effect) 
and increasing cerebral blood flow 20. In these human studies, KB supplementation 
was shown to have additional positive systemic effects, by stabilizing blood glucose 
to normal levels 19. Altogether, these data provide the rationale for future clinical 
investigation of ketone therapy during the acute phase of TBI. Long-term progressive 
neurodegeneration following TBI also may be potentially amenable to enteral KB 
supplementation, as in other neurodegenerative disorders 10. 
Future perspectives 
TBI constitutes a persistent challenge to global health care, being the leading cause 
of mortality in young adults and a major cause of death and disability across all ages 
worldwide, with a disproportionate burden of disability occurring in low-income and 
middle-income countries 21. Given the current lack of targeted pharmacological 
therapies, boosting neuroenergetics with lactate or ketone therapy may be a valid 
therapeutic approach to attenuate secondary energy dysfunction, with various 
additional potentially favorable effects against acute phase and progressive 
neurodegenerative post-TBI processes (Figure 1). This approach appears relatively 
safe, inexpensive and therefore easily available worldwide, supporting the conduct of 



































































1. Carpenter KL, Jalloh I, Hutchinson PJ (2015) Glycolysis and the significance of
lactate in traumatic brain injury. Front Neurosci 9:112 
2. Glenn TC, Martin NA, Horning MA, McArthur DL, Hovda DA, Vespa P, Brooks GA
(2015) Lactate: brain fuel in human traumatic brain injury: a comparison with normal 
healthy control subjects. J Neurotrauma. 2015 32:820-32   
3. Magistretti PJ, Allaman I (2018) Lactate in the brain: from metabolic end-product to
signalling molecule. Nat Rev Neurosci 19:235-249 
4. Zhou J, Burns MP, Huynh L, Villapol S, Taub DD, Saavedra JM, Blackman MR.
(2017) Temporal changes in cortical and hippocampal expression of genes important 
for brain glucose metabolism following controlled cortical impact injury in mice. Front 
Endocrinol 8:231 
5. Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A (2018) Intermittent
metabolic switching, neuroplasticity and brain health Nat Rev Neurosci 19:63-80 
6. Jalloh I, Helmy A, Howe DJ, Shannon RJ, Grice P, Mason A, Gallagher CN,
Murphy MP, Pickard JD, Menon DK et al (2018) A Comparison of Oxidative Lactate 
Metabolism in Traumatically Injured Brain and Control Brain J Neurotrauma 35:2025-
2035 
7. Wolahan SM, Mao HC, Real C, Vespa PM, Glenn TC (2018) Lactate
supplementation in severe traumatic brain injured adults by primed constant infusion 
of sodium L-lactate J Neurosci Res 96:688-695 
8. Carteron L, Solari D, Patet C, Quintard H, Miroz JP, Bloch J, Daniel RT, Hirt L,
Eckert P, Magistretti PJ et al (2018) Hypertonic lactate to improve cerebral perfusion 
and glucose availability after acute brain injury Crit Care Med 46:1649-1655 
9. Ichai C, Payen JF, Orban JC, Quintard H, Roth H, Legrand R, Francony G,
Leverve XM (2013) Half-molar sodium lactate infusion to prevent intracranial 
hypertensive episodes in severe traumatic brain injured patients: a randomized 
controlled trial Intensive Care Med 39:1413-22 
10. Augustin K, Khabbush A, Williams S, Eaton S, Orford M, Cross JH, Heales SJR,
Walker MC, Williams RSB (2018) Mechanisms of action for the medium-chain 
triglyceride ketogenic diet in neurological and metabolic disorders Lancet Neurol 
17:84-93 
11. Stubbs BJ, Cox PJ, Evans RD, Santer P, Miller JJ, Faull OK, Magor-Elliott S,
Hiyama S, Stirling M, Clarke K (2017) On the Metabolism of Exogenous Ketones in 


































































12. Xin L, Ipek Ö, Beaumont M, Shevlyakova M, Christinat N, Masoodi M, Greenberg
N, Gruetter R, Cuenoud B (2018) Nutritional Ketosis Increases NAD+/NADH Ratio in 
Healthy Human Brain: An in Vivo Study by 31P-MRS Front Nutr 2018 5:62  
13. Hashim SA, VanItallie TB (2014) Ketone body therapy: from the ketogenic diet to
the oral administration of ketone ester J Lipid Res 55:1818-26 
14. White H, Venkatesh B (2011) Clinical review: ketones and brain injury Crit Care
15:219 
15. Prins ML, Matsumoto JH (2014) The collective therapeutic potential of
cerebral ketone metabolism in traumatic brain injury J Lipid Res 55:2450-7 
16. Kim DY, Simeone KA, Simeone TA, Pandya JD, Wilke JC, Ahn Y, Geddes JW,
Sullivan PG, Rho JM (2015) Ketone bodies mediate antiseizure effects through 
mitochondrial permeability transition Ann Neurol 78:77-87 
17. Greco T, Glenn TC, Hovda DA, Prins ML (2016) Ketogenic diet decreases
oxidative stress and improves mitochondrial respiratory complex activity J Cereb 
Blood Flow Metab 36:1603-13 
18. Bernini A, Masoodi M, Solari D, Miroz JP, Carteron L, Christinat N, Morelli P,
Beaumont M, Abed-Maillard S, Hartweg M et al Modulation of cerebral ketone 
metabolism following traumatic brain injury in humans (2018) J Cereb Blood Flow 
Metab Oct 24:271678X18808947 [Epub ahead of print] 
19. Cox PJ, Kirk T, Ashmore T, Willerton K, Evans R, Smith A, Murray AJ, Stubbs B,
West J, McLure SW et al (2016) Nutritional Ketosis Alters Fuel Preference and 
Thereby Endurance Performance in Athletes Cell Metab 24:256-68 
20. Svart M, Gormsen LC, Hansen J, Zeidler D, Gejl M, Vang K, Aanerud J, Moeller
N (2018) Regional cerebral effects of ketone body infusion with 3-hydroxybutyrate in 
humans: Reduced glucose uptake, unchanged oxygen consumption and increased 
blood flow by positron emission tomography. A randomized, controlled trial PLoS 
One. 13 e0190556 
21. Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, Bragge P,
Brazinova A, Büki A, Chesnut RM et al (2017) Traumatic brain injury: integrated 




































































Figure 1. Rationale for therapies aimed at improving neuroenergetics following 
traumatic brain injury. 
Pathophysiologic mechanisms of secondary cerebral damage following traumatic 
brain injury (TBI) involve acute phase (≈0-7 days; green box) and progressive (>7 
days-weeks; orange box) mechanisms that contribute to aggravate the initial injury 
and overall patient prognosis. Interventions targeted to improve neuroenergetics – 
such as lactate therapy (in blue) or ketone therapy (in red), by counteracting TBI 
mechanisms at various levels (arrows), have the potential to attenuate secondary 
cerebral damage.  
Abbreviations: BHB, -hydroxybutyrate; CBF, cerebral blood flow; HDAC, histone 
deacetylase; ICP, intracranial pressure; KD, ketogenic diet; KE, ketone esters; KS, 
ketone salts; L/P, lactate/pyruvate; NAD+, nicotinamide adenine dinucleotide 
(oxidized); NADH nicotinamide adenine dinucleotide (reduced); PPP, pentose-
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